Scholarlink

Background <p>Accurate tumor delineation in somatostatin receptor (SSTR) PET/CT is imperative for quantifying tumor burden, therapy monitoring, and response assessment in gastroenteropancreatic neuroendocrine tumors (GEPNETs). This study aimed to evaluate different SSTR PET-based tumor delineation approaches, based on a lymph node metastasis as reference standard, and determine the most robust method for volume assessment. Singular, non-bulky lymph node metastases with a short axis diameter ≥ 1.0&#xa0;cm from [¹⁸F]SiTATE PET/CT scans were included. Different tumor delineation methods were applied: fixed SUV thresholds, isocontours relative to SUV<sub>max</sub>, and individual backwards thresholding. The correlation between PET-derived volumes and CT-derived volumes (reference standard) were investigated.</p> Results <p>An isocontour approach using 45% of SUV<sub>max</sub> demonstrated the strongest correlation with CT-derived volumes (<i>r</i> = 0.874; r² = 0.764; <i>p</i> &lt; 0.001), outperforming fixed SUV thresholds, e.g. SUV 4.0 (<i>r</i> = 0.727; r<sup>2</sup> = 0.529; <i>p</i> &lt; 0.001). The application of a backwards threshold approach resulted in the identification of significant variability (CoV: 59.6% for fixed SUV, 31.3% for isocontour).</p> Conclusion <p>The 45% isocontour-thresholding relative to lesional SUV<sub>max</sub> approach constitutes a robust and clinically applicable method for SSTR PET-based tumor delineation in GEPNET patients, irrespective of changes of SSTR avidity of reference tissues (e.g. liver). Further validation is required to establish its role in total tumor volume assessment and therapy monitoring.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Feasibility of different lymph node metastases delineation approaches in [18F]SiTATE PET/CT imaging in NET patients

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月30日

查看全文
  • Sophie Carina Siegmund,
  • Magdalena Schöll,
  • Vera U. Wenter,
  • Gabriel T. Sheikh,
  • Maximilian Scheifele,
  • Franz Josef Gildehaus,
  • Simon Lindner,
  • Lalith K. Shiyam Sundar,
  • Christine Spitzweg,
  • Christoph J. Auernhammer,
  • Rudolf A. Werner,
  • Mathias J. Zacherl

摘要

Background

Accurate tumor delineation in somatostatin receptor (SSTR) PET/CT is imperative for quantifying tumor burden, therapy monitoring, and response assessment in gastroenteropancreatic neuroendocrine tumors (GEPNETs). This study aimed to evaluate different SSTR PET-based tumor delineation approaches, based on a lymph node metastasis as reference standard, and determine the most robust method for volume assessment. Singular, non-bulky lymph node metastases with a short axis diameter ≥ 1.0 cm from [¹⁸F]SiTATE PET/CT scans were included. Different tumor delineation methods were applied: fixed SUV thresholds, isocontours relative to SUVmax, and individual backwards thresholding. The correlation between PET-derived volumes and CT-derived volumes (reference standard) were investigated.

Results

An isocontour approach using 45% of SUVmax demonstrated the strongest correlation with CT-derived volumes (r = 0.874; r² = 0.764; p < 0.001), outperforming fixed SUV thresholds, e.g. SUV 4.0 (r = 0.727; r2 = 0.529; p < 0.001). The application of a backwards threshold approach resulted in the identification of significant variability (CoV: 59.6% for fixed SUV, 31.3% for isocontour).

Conclusion

The 45% isocontour-thresholding relative to lesional SUVmax approach constitutes a robust and clinically applicable method for SSTR PET-based tumor delineation in GEPNET patients, irrespective of changes of SSTR avidity of reference tissues (e.g. liver). Further validation is required to establish its role in total tumor volume assessment and therapy monitoring.